Literature DB >> 15291813

Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.

Didier Belorgey1, Lynda K Sharp, Damian C Crowther, Maki Onda, Jan Johansson, David A Lomas.   

Abstract

The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291813     DOI: 10.1111/j.1432-1033.2004.04270.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

1.  Tissue plasminogen activator, neuroserpin, and seizures.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

2.  Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.

Authors:  Giovanna Galliciotti; Markus Glatzel; Jochen Kinter; Serguei V Kozlov; Paolo Cinelli; Thomas Rülicke; Peter Sonderegger
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

Review 3.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

Review 4.  The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.

Authors:  Alessandro Orsini; Angelo Valetto; Veronica Bertini; Mariagrazia Esposito; Niccolò Carli; Berge A Minassian; Alice Bonuccelli; Diego Peroni; Roberto Michelucci; Pasquale Striano
Journal:  Seizure       Date:  2019-08-23       Impact factor: 3.184

5.  Two latent and two hyperstable polymeric forms of human neuroserpin.

Authors:  Stefano Ricagno; Margherita Pezzullo; Alberto Barbiroli; Mauro Manno; Matteo Levantino; Maria Grazia Santangelo; Francesco Bonomi; Martino Bolognesi
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

6.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

7.  Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.

Authors:  Albert Chiou; Peter Hägglöf; Angel Orte; Allen Yuyin Chen; Paul D Dunne; Didier Belorgey; Susanna Karlsson-Li; David A Lomas; David Klenerman
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

8.  The tempered polymerization of human neuroserpin.

Authors:  Rosina Noto; Maria Grazia Santangelo; Stefano Ricagno; Maria Rosalia Mangione; Matteo Levantino; Margherita Pezzullo; Vincenzo Martorana; Antonio Cupane; Martino Bolognesi; Mauro Manno
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

9.  Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner.

Authors:  Ping-Yen Chen; Wun-Shaing W Chang; Ruey-Hwang Chou; Yiu-Kay Lai; Sheng-Chieh Lin; Chia-Yi Chi; Cheng-Wen Wu
Journal:  BMC Mol Biol       Date:  2007-01-09       Impact factor: 2.946

10.  The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB.

Authors:  Elena Miranda; Ian MacLeod; Mark J Davies; Juan Pérez; Karin Römisch; Damian C Crowther; David A Lomas
Journal:  Hum Mol Genet       Date:  2008-02-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.